Self-Assembling Amphiphilic Peptides Target the VDAC1-Hexokinase-II Complex to Induce Apoptosis in Cervical Carcinoma Cells
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Wanfeng Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, China. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Apoptosis, Uterine Cervical Neoplasms, Hexokinase. Die Arbeit nennt 37 Literaturangaben. Gefördert von: European Regional Development Fund, Grantov? Agentura Cesk? Republiky, National Natural Science Foundation of China.
Abstract (Originalsprache)
VDAC1, an outer mitochondrial membrane protein overexpressed in cancers, regulates apoptosis by interacting with antiapoptotic proteins and releasing apoptotic factors. We investigate novel multiblock cationic peptide amphiphiles targeting the VDAC1-Hexokinase-II complex in the mitochondria of cervical carcinoma cells. Amphiphilic peptide variants were designed by modifying the C-terminus of VDAC1 fragment LP1 with a cationic hydrophilic segment and the N-terminus with a hydrophobic domain, enabling self-assembly into nanofiber-like structures at elevated concentrations. In HeLa cells, these peptides triggered mitochondrial-mediated apoptosis through a decrease of the mitochondrial membrane potential, cytochrome C release, and caspase activation, suggesting a disrupted VDAC1-HK-II interaction. The mitochondria-targeting peptides showed notable selective cytotoxicity to cancer cells, with minimal effects on normal 3T3 cells. Our findings demonstrate that amphiphilic peptides for VDAC1-HK-II-targeting represent a promising mitochondria-focused therapeutic strategy for cervical cancer inhibition, combining structural self-assembly properties with enhanced apoptotic efficacy in malignant cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, China.
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay F-91400, France.
- College of Chemistry and Materials Science, Shanghai Normal University, 100 Guilin RD, Shanghai 200234, China.
- Department of Structural Dynamics, Extreme Light Infrastructure ERIC, Dolni Brezany CZ-25241, Czech Republic.
- National Facility for Protein Science in Shanghai Zhangjiang Laboratory, Shanghai Advanced Research Institute, CAS, Shanghai 20124, China.
ORCID-Profile: Angelina Angelova, Xintong Han, Borislav Angelov, Qibin Chen, Na Li, Aihua Zou
Förderung
- European Regional Development Fund
- Grantov? Agentura Cesk? Republiky
- National Natural Science Foundation of China
- Johannes Amos Comenius Operational Program OPJAK
Zitieren
APA
Sun, W., Angelova, A., Han, X., Wang, X., Angelov, B., Chen, Q., Li, N., & Zou, A. (2025). Self-Assembling Amphiphilic Peptides Target the VDAC1-Hexokinase-II Complex to Induce Apoptosis in Cervical Carcinoma Cells. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02789
Vancouver
Sun W, Angelova A, Han X, Wang X, Angelov B, Chen Q, et al. Self-Assembling Amphiphilic Peptides Target the VDAC1-Hexokinase-II Complex to Induce Apoptosis in Cervical Carcinoma Cells. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02789
BibTeX
@article{Sun2025,
author = {Sun, Wanfeng and Angelova, Angelina and Han, Xintong and Wang, Xibai and Angelov, Borislav and Chen, Qibin and Li, Na and Zou, Aihua},
title = {Self-Assembling Amphiphilic Peptides Target the VDAC1-Hexokinase-II Complex to Induce Apoptosis in Cervical Carcinoma Cells},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02789}
}
EUVIMED